OTCMKTS:ZRSEF - Zur Rose Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 6
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$377.00
▲ +7 (1.89%)
1 month | 3 months | 12 months
Get New Zur Rose Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZRSEF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZRSEF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Zur Rose Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $377.00.
Buy
The current consensus among 6 contributing investment analysts is to buy stock in Zur Rose Group.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/18/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetDetails
3/30/2021UBS GroupReiterated RatingSell
i
3/29/2021Morgan StanleyInitiated CoverageOverweight
i
3/23/2021Morgan StanleyInitiated CoverageOverweight
i
2/8/2021Berenberg BankReiterated RatingBuy
i
1/29/2021CitigroupDowngradeBuy ➝ Neutral
i
1/22/2021BarclaysReiterated RatingOverweight
i
7/17/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
7/7/2020BarclaysReiterated RatingOverweight
i
(Data available from 4/19/2016 forward)
Zur Rose Group logo
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. The company offers consumer health, beauty, and personal care products. It also provides medicines management services. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. In addition, it operates stationary pharmacy shops. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Read More

Today's Range

Now: $377.00
$367.00
$377.00

50 Day Range

MA: $446.23
$370.00
$547.00

52 Week Range

Now: $377.00
$363.80
$547.00

Volume

100 shs

Average Volume

262 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Zur Rose Group?

The following Wall Street sell-side analysts have issued stock ratings on Zur Rose Group in the last year: Barclays PLC, Berenberg Bank, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Morgan Stanley, and UBS Group AG.
View the latest analyst ratings for ZRSEF.

What is the current price target for Zur Rose Group?

0 Wall Street analysts have set twelve-month price targets for Zur Rose Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Zur Rose Group in the next year.
View the latest price targets for ZRSEF.

What is the current consensus analyst rating for Zur Rose Group?

Zur Rose Group currently has 1 sell rating, 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ZRSEF will outperform the market and that investors should add to their positions of Zur Rose Group.
View the latest ratings for ZRSEF.

What other companies compete with Zur Rose Group?

Other companies that are similar to Zur Rose Group include Allstar Health Brands, Clicks Group, Fire & Flower, High Tide, Raia Drogasil, Shop Apotheke Europe, Sundrug Co.,Ltd. and Tsuruha.

How do I contact Zur Rose Group's investor relations team?

The company's listed phone number is 41 52 724 00 20. The official website for Zur Rose Group is www.zurrosegroup.com.